The Goldman Sachs Group vs Pfizer Inc.
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
The Goldman Sachs Group (GS) carries a "Neutral" signal with -3.8% revenue growth, while Pfizer Inc. (PFE) is "Neutral" with -18.4% revenue growth. Both companies report in the Financials and Healthcare sectors.
| Metric | The Goldman Sachs Group (GS) | Pfizer Inc. (PFE) |
|---|---|---|
| Operator Signal | Neutral | Neutral |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $20.6B | $14.5B |
| Revenue Growth | -3.8%* | -18.4% |
| Latest EPS | $17.55* | $0.47 |
| EPS Growth | 108.9%* | -39.7% |
| Sector | Financials | Healthcare |
| Quarters Tracked | 8 | 8 |
The Goldman Sachs Group (GS) carries a "Neutral" signal with -3.8% revenue growth, while Pfizer Inc. (PFE) is "Neutral" with -18.4% revenue growth. Both companies report in the Financials and Healthcare sectors.